Pacira BioSciences saw the highest growth of 4.99% in patent filings in May and 0.74% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.74%. GlobalData’s DataBook provides a comprehensive analysis of Pacira BioSciences’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Pacira BioSciences has been focused on protecting inventions in United States(US) with eight publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 31% filings and 60% grants. The United States(US), United Kingdom(GB), China(CN), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Pacira BioSciences is filings its patents. Among the top granted patent authorities, Pacira BioSciences has 60% of its grants in United States(US), 20% in United Kingdom(GB) and 20% in European Patent Office(EPO).
Roche and Johnson & Johnson could be the strongest competitors for Pacira BioSciences
Patents related to nanomedicine and healthtech lead Pacira BioSciences's portfolio
Pacira BioSciences has the highest number of patents in nanomedicine followed by, healthtech. For nanomedicine, nearly 83% of patents were filed and no patents were granted in Q2 2024.
General surgery devices related patents lead Pacira BioSciences portfolio followed by pain, and neurology devices
Pacira BioSciences has highest number of patents in general surgery devices followed by pain, neurology devices, anxiety disorders, and generalized anxiety disorder (gad). For general surgery devices, nearly 12% of patents were filed and 50% of patents were granted in Q2 2024.
For comprehensive analysis of Pacira BioSciences's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
